Growing corporate cash balances and slowing organic-growth opportunities could lead to increased deal volume this year even if economic uncertainty throttles some activity, says Morningstar's Bridget Freas.
Five stats from the market and the stories behind them. This week: Berkshire's stake in a $28 billion deal, Avon's not-so-pretty 1% sales growth, and more.
Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.
Welcome to the Fourth Quarter 2012 BioMed Realty Trust Earnings Conference Call. My name is Larissa and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Please note that this conference is being recorded. Later we will conduct a question-and-answer ...
Good morning and welcome to the Precision Castparts' Webcast and Conference Call to discuss its third quarter for Fiscal 2013. This event is being recorded and will be available on PCC's Company website at www.precast.com, shortly after the conclusion of the presentation and discussion. Following ...
Good morning and welcome to the Alexion Pharmaceuticals Incorporated Fourth Quarter and Full Year 2012 Results Conference Call. Today's call is being recorded.
This year, Duran said the company plans to aggressively expand its business model, and its brand -- aiming to look more like Starbucks and less like rivals HighTower and Dynasty Financial.